220 related articles for article (PubMed ID: 28927906)
1. IL-17A contributes to reducing IFN-γ/IL-4 ratio and persistence of Entamoeba histolytica during intestinal amebiasis.
Deloer S; Nakamura R; Kikuchi M; Moriyasu T; Kalenda YDJ; Mohammed ES; Senba M; Iwakura Y; Yoshida H; Hamano S
Parasitol Int; 2017 Dec; 66(6):817-823. PubMed ID: 28927906
[TBL] [Abstract][Full Text] [Related]
2. Persistence of Entamoeba histolytica infection in CBA mice owes to intestinal IL-4 production and inhibition of protective IFN-gamma.
Guo X; Stroup SE; Houpt ER
Mucosal Immunol; 2008 Mar; 1(2):139-46. PubMed ID: 19079171
[TBL] [Abstract][Full Text] [Related]
3. Intestinal Inflammation-Mediated Clearance of Amebic Parasites Is Dependent on IFN-γ.
Shimokawa C; Senba M; Kobayashi S; Kikuchi M; Obi S; Olia A; Hamano S; Hisaeda H
J Immunol; 2018 Feb; 200(3):1101-1109. PubMed ID: 29255076
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow dendritic cells from mice with an altered microbiota provide interleukin 17A-dependent protection against Entamoeba histolytica colitis.
Burgess SL; Buonomo E; Carey M; Cowardin C; Naylor C; Noor Z; Wills-Karp M; Petri WA
mBio; 2014 Nov; 5(6):e01817. PubMed ID: 25370489
[TBL] [Abstract][Full Text] [Related]
5. CCR9+ T cells contribute to the resolution of the inflammatory response in a mouse model of intestinal amoebiasis.
Rojas-López AE; Soldevila G; Meza-Pérez S; Dupont G; Ostoa-Saloma P; Wurbel MA; Ventura-Juárez J; Flores-Romo L; García-Zepeda EA
Immunobiology; 2012 Aug; 217(8):795-807. PubMed ID: 22633147
[TBL] [Abstract][Full Text] [Related]
6. The IL-33-ILC2 pathway protects from amebic colitis.
Uddin MJ; Leslie JL; Burgess SL; Oakland N; Thompson B; Abhyankar M; Revilla J; Frisbee A; Donlan AN; Kumar P; Petri WA
Mucosal Immunol; 2022 Jan; 15(1):165-175. PubMed ID: 34400793
[TBL] [Abstract][Full Text] [Related]
7. Human intestinal epithelial cells produce proinflammatory cytokines in response to infection in a SCID mouse-human intestinal xenograft model of amebiasis.
Seydel KB; Li E; Swanson PE; Stanley SL
Infect Immun; 1997 May; 65(5):1631-9. PubMed ID: 9125540
[TBL] [Abstract][Full Text] [Related]
8. Host-antibody inductivity of virulent Entamoeba histolytica and non-virulent Entamoeba moshkovskii in a mouse model.
Khomkhum N; Leetachewa S; Pawestri AR; Moonsom S
Parasit Vectors; 2019 Mar; 12(1):101. PubMed ID: 30867040
[TBL] [Abstract][Full Text] [Related]
9. Entamoeba histolytica infection in children and protection from subsequent amebiasis.
Haque R; Mondal D; Duggal P; Kabir M; Roy S; Farr BM; Sack RB; Petri WA
Infect Immun; 2006 Feb; 74(2):904-9. PubMed ID: 16428733
[TBL] [Abstract][Full Text] [Related]
10. Protozoa. Amebiasis.
Li E; Stanley SL
Gastroenterol Clin North Am; 1996 Sep; 25(3):471-92. PubMed ID: 8863036
[TBL] [Abstract][Full Text] [Related]
11. The mouse model of amebic colitis reveals mouse strain susceptibility to infection and exacerbation of disease by CD4+ T cells.
Houpt ER; Glembocki DJ; Obrig TG; Moskaluk CA; Lockhart LA; Wright RL; Seaner RM; Keepers TR; Wilkins TD; Petri WA
J Immunol; 2002 Oct; 169(8):4496-503. PubMed ID: 12370386
[TBL] [Abstract][Full Text] [Related]
12. Resistance to intestinal Entamoeba histolytica infection is conferred by innate immunity and Gr-1+ cells.
Asgharpour A; Gilchrist C; Baba D; Hamano S; Houpt E
Infect Immun; 2005 Aug; 73(8):4522-9. PubMed ID: 16040963
[TBL] [Abstract][Full Text] [Related]
13. Entamoeba histolytica: Overexpression of the gal/galnac lectin, ehcp2 and ehcp5 genes in an in vivo model of amebiasis.
Sánchez V; Serrano-Luna J; Ramírez-Moreno E; Tsutsumi V; Shibayama M
Parasitol Int; 2016 Dec; 65(6 Pt A):665-667. PubMed ID: 27616150
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive intestinal amebiasis: Entamoeba histolytica colonization without invasion.
Nair GV; Variyam EP
Curr Opin Infect Dis; 2014 Oct; 27(5):465-9. PubMed ID: 25101557
[TBL] [Abstract][Full Text] [Related]
15. Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica.
Abhyankar MM; Noor Z; Tomai MA; Elvecrog J; Fox CB; Petri WA
Vaccine; 2017 Feb; 35(6):916-922. PubMed ID: 28089548
[TBL] [Abstract][Full Text] [Related]
16. Protection against intestinal amebiasis by a recombinant vaccine is transferable by T cells and mediated by gamma interferon.
Guo X; Barroso L; Becker SM; Lyerly DM; Vedvick TS; Reed SG; Petri WA; Houpt ER
Infect Immun; 2009 Sep; 77(9):3909-18. PubMed ID: 19564375
[TBL] [Abstract][Full Text] [Related]
17. The expression of REG 1A and REG 1B is increased during acute amebic colitis.
Peterson KM; Guo X; Elkahloun AG; Mondal D; Bardhan PK; Sugawara A; Duggal P; Haque R; Petri WA
Parasitol Int; 2011 Sep; 60(3):296-300. PubMed ID: 21586335
[TBL] [Abstract][Full Text] [Related]
18. Host immune response to intestinal amebiasis.
Moonah SN; Jiang NM; Petri WA
PLoS Pathog; 2013; 9(8):e1003489. PubMed ID: 23990778
[No Abstract] [Full Text] [Related]
19. IL-22 mediates host defense against an intestinal intracellular parasite in the absence of IFN-γ at the cost of Th17-driven immunopathology.
Stange J; Hepworth MR; Rausch S; Zajic L; Kühl AA; Uyttenhove C; Renauld JC; Hartmann S; Lucius R
J Immunol; 2012 Mar; 188(5):2410-8. PubMed ID: 22266282
[TBL] [Abstract][Full Text] [Related]
20. Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VI. Entamoeba histolytica: parasite-host interactions.
Stanley SL; Reed SL
Am J Physiol Gastrointest Liver Physiol; 2001 Jun; 280(6):G1049-54. PubMed ID: 11352795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
